Insider trades

Rodriguez Raul R., CEO of Rigel Pharmaceuticals RIGL, has filed 0 purchases and 5 sales on the open market. The latest trade was on 06/17.

Rodriguez Raul R.

CEO, President
First filing
23/01/30
Trades
36 trades
Buys / sales
0 / 5
12-month net buying
No record
Last trade
06/17

Trading activity

Transactions

Trade type
RIGL
Open-market sale25/02/04–25/02/0525/02/069,352 sh2 trades$21.40avg.$200,087.84−3.8%
RIGL
Open-market sale24/02/02–24/02/0524/02/0652,894 sh2 trades$1.14avg.$60,075.67−2.5%
Open-market sale23/02/0623/02/0720,340 sh$1.75$35,595−1.2%